de Lange, K.M., Moutsianas, L., Lee, J.C., et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet 49 (2017), 256–261.
Imhann, F., Vich Vila, A., Bonder, M.J., et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut 67 (2018), 108–119.
Rivas, M.A., Beaudoin, M., Gardet, A., et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43 (2011), 1066–1073.
Schirmer, M., Franzosa, E.A., Lloyd-Price, J., et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat Microbiol 3 (2018), 337–346.
Li, Y., Oosting, M., Smeekens, S.P., et al. A functional genomics approach to understand variation in cytokine production in humans. Cell 167 (2016), 1099–1110.
Ivison, S., Des Rosiers, C., Lesage, S., et al. Biomarker-guided stratification of autoimmune patients for biologic therapy. Curr Opin Immunol 49 (2017), 56–63.
Yang, S.K., Hong, M., Baek, J., et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet 46 (2014), 1017–1020.
Pariente, B., Cosnes, J., Danese, S., et al. Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis 17 (2011), 1415–1422.
